Menin/PRMT5/hedgehog signaling: A potential target for the treatment of multiple endocrine neoplasia type 1 tumors

Epigenomics

Volumn 5, Issue 5, 2013, Pages 469-471

  Gurung, Buddha ^a   Hua, Xianxin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

MEN1; menin; PRMT5

Indexed keywords

CELL MEMBRANE PROTEIN; CELL SURFACE RECEPTOR; HISTONE H4; HISTONE METHYLTRANSFERASE; MESSENGER RNA; METHIONINE; VISMODEGIB;

ALOPECIA; BASAL CELL CARCINOMA; CANCER RECURRENCE; CANCER THERAPY; EMBRYO DEVELOPMENT; EPIGENETIC REPRESSION; EPIGENETICS; FATIGUE; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; GENETIC SCREENING; GENETIC TRANSCRIPTION; GLUCOSE INTOLERANCE; HEDGEHOG; HISTONE METHYLATION; HUMAN; IN VITRO STUDY; INSULIN RELEASE; INSULINOMA; LEUKEMIA; LUNG SMALL CELL CANCER; MEDULLOBLASTOMA; METASTATIC COLORECTAL CANCER; MOUSE MODEL; MULTIPLE ENDOCRINE NEOPLASIA; MUSCLE SPASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OVARY CANCER; PANCREAS ADENOCARCINOMA; PANCREAS ISLET; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TASTE DISORDER; WILD TYPE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; SIGNAL TRANSDUCTION;

HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; SIGNAL TRANSDUCTION;

EID: 84885014725     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.47     Document Type: Review

References (26)

1. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat. Rev. Cancer 5(5), 367-375 (2005).
2. Chandrasekharappa SC, Guru SC, Manickam P et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311), 404-407 (1997).
3. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum. Mutat. 29(1), 22-32 (2008).
4. Huang J, Gurung B, Wan B et al. The same pocket in menin binds both MLL and JUND but has opposite effects on transcription. Nature 482(7386), 542-546 (2012).
5. Agarwal SK, Guru SC, Heppner C et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96(1), 143-152 (1999).
6. Milne TA, Hughes CM, Lloyd R et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl Acad. Sci. USA 102(3), 749-754 (2005).
7. Karnik SK, Hughes CM, Gu X et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl Acad. Sci. USA 102(41), 14659-14664 (2005).
8. Thiel AT, Blessington P, Zou T et al. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell 17(2), 148-159 (2010).
9. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes. Mol. Cell Biol. 24(21), 9630-9645 (2004).
10. Gurung B, Feng Z, Iwamoto DV et al. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome. Cancer Res. 73(8), 2650-2658 (2013).
11. Allen BL, Song JY, Izzi L et al. Overlapping roles and collective requirement for the coreceptors GAS1, CDO, and BOC in SHH pathway function. Dev. Cell 20(6), 775-787 (2011).
12. Martinelli DC, Fan CM. Gas1 extends the range of Hedgehog action by facilitating its signaling. Genes Dev. 21(10), 1231-1243 (2007).
13. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev. Cell 15(6), 801-812 (2008).
14. Xie J, Murone M, Luoh SM et al. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature 391(6662), 90-92 (1998).
15. Thompson MC, Fuller C, Hogg TL et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 24(12), 1924-1931 (2006).
16. Shida T, Furuya M, Nikaido T et al. Sonic hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine carcinomas. Cancer Biol. Ther. 5(11), 1530-1538 (2006).
17. Park KS, Martelotto LG, Peifer M et al. A crucial requirement for hedgehog signaling in small cell lung cancer. Nat. Med. 17(11), 1504-1508 (2011).
18. Lau J, Hebrok M. Hedgehog signaling in pancreas epithelium regulates embryonic organ formation and adult b-cell function. Diabetes 59(5), 1211-1221 (2010).
19. Olive KP, Jacobetz MA, Davidson CJ et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324(5933), 1457-1461 (2009).
20. Crabtree JS, Scacheri PC, Ward JM et al. Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol. Cell Biol. 23(17), 6075-6085 (2003).
21. Rudin CM, Hann CL, Laterra J et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 361(12), 1173-1178 (2009).
22. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br. J. Surg. 93(3), 264-275 (2006).
23. Hausman MS Jr, Thompson NW, Gauger PG, Doherty GM. The surgical management of MEN-1 pancreatoduodenal neuroendocrine disease. Surgery 136(6), 1205-1211 (2004).
24. Sekulic A, Migden MR, Oro AE et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N. Engl. J. Med. 366(23), 2171-2179 (2012).
25. A study of GDC-0449 (hedgehog pathway inhibitor) in patients treated with GDC-0449 in a previous Genentech-sponsored Phase I or II cancer study. http://clinicaltrials.gov/ct2/show/NCT00959647?term=NCT00959647&rank=1
26. GDC-0449 and erlotinib hydrochloride with or without gemcitabine hydrochloride in treating patients with metastatic pancreatic cancer or solid tumors that cannot be removed by surgery. http://clinicaltrials.gov/ct2/show/ NCT00878 163?term=NCT00878163&rank=1